Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2009-01-16
2011-10-25
Kim, Jennifer M (Department: 1628)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
Reexamination Certificate
active
08044096
ABSTRACT:
This invention relates to a method of treating addiction using a composition containing quercetin. Preferably, it also contains vitamin B3, and vitamin C.
REFERENCES:
patent: 5026721 (1991-06-01), Dudrick et al.
patent: 5804594 (1998-09-01), Murad
patent: 5846569 (1998-12-01), Anderson et al.
patent: 6103756 (2000-08-01), Gorsek
patent: 6203818 (2001-03-01), Vester
patent: 6210701 (2001-04-01), Darland et al.
patent: 6261589 (2001-07-01), Pearson et al.
patent: 6277426 (2001-08-01), Reust
patent: 6277427 (2001-08-01), Husz
patent: 6299925 (2001-10-01), Xiong et al.
patent: 6352712 (2002-03-01), Lukaczer et al.
patent: 6491948 (2002-12-01), Buchholz et al.
patent: 6511675 (2003-01-01), Siddiqui et al.
patent: 6551629 (2003-04-01), Gorsek
patent: 6579544 (2003-06-01), Rosenberg et al.
patent: 6821536 (2004-11-01), Lines et al.
patent: 7041652 (2006-05-01), Buchholz et al.
patent: 7270840 (2007-09-01), Lines et al.
patent: 2002/0025350 (2002-02-01), Siddiqui et al.
patent: 2002/0151599 (2002-10-01), Buchholz et al.
patent: 2003/0054357 (2003-03-01), Young et al.
patent: 2003/0068391 (2003-04-01), Harris et al.
patent: 2004/0126461 (2004-07-01), Lines et al.
patent: 2004/0132671 (2004-07-01), Zhao et al.
patent: 2005/0031737 (2005-02-01), Lines et al.
patent: 2005/0266121 (2005-12-01), Lines et al.
patent: 2006/0204601 (2006-09-01), Palu et al.
patent: 2007/0148210 (2007-06-01), Lines et al.
patent: 2007/0190114 (2007-08-01), Smart
patent: WO95-29668 (1995-11-01), None
patent: WO 98/41195 (1998-09-01), None
patent: WO 00/12085 (2000-03-01), None
patent: WO 02/07768 (2002-01-01), None
patent: WO 2008/011364 (2008-01-01), None
Bors et al., “Flavanoids and Polyphenols: Chemistry and Biology,”Handbook of Antioxidants, pp. 409-416 (1996).
Chow et al., “Phase I Pharmacokinetic Study of Tea Polyphenols Following Single-dose Administration of Epigallocatechin Gallate and Polyphenon E,” Cancer Epidemiology, Biomarkers & Prevention 10:53-58 (2001) XP-002366662.
Crespy et al., “Quercetin, but not Its Glycosides, Is Absorbed from the Rat Stomach,” Journal of Agricultural and Food Chemistry, vol. 50, pp. 68-621 (2002).
Dequan et al., “Survey of Bioflavonoids,” Food and Fermentation Industries, 25(16): 52-56 (1999) (Translation of English Abstract).
Erlund et al., “Pharmacokinetics of Quercetin from Quercetin Aglycone and Rutin in Healthy Volunteers,” Eur. J. Clin. Pharmacol., 56:545-553 (2000).
Guardia et al., “Anti-Inflammatory Properties of Plant Flavinoids. Effect of Rutin, Quercetin and Hesperidin on Adjuvant Arthritis in Rat,” Il Farmaco, 56: 683-687 (2001).
Koo et al., “Pharmacological Effects of Green Tea on the Gastrointestinal System,” European Journal of Pharmacology 500:177-184 (2004).
Min et al., “The Chemistry and Medical Application of Tea Polyphenol,” Hubei Chemical Industry, 2001, 3, 29-31 (Translation of English Abstract).
Saucier et al., “Synergetic Activity of Catechin and Other Antioxidants,” Journal of Agricultural and Food Chemistry, 47(11): 4491-4494 (1999).
Sesink et al., “Quercetin Glucuronides but Not Glucosides Are Present in Human Plasma After Consumption of Quercetin-3-Glucoside or Quercetin-4-Glucoside,” Human Nutrition and Metabolism Research Communication, pp. 1938-1941 (2001).
Thomas et al., “Ascorbate and Phenolic Antioxidant Interations in Prevention of Liposomal Oxidation,” Lipids 27(7) (1992).
Walle et al., “Quercetin Glucosides Are Completely Hydrolyzed in Ileostomy Patients before Absorption,” Human Nutrition and Metabolism Research Communication, pp. 2658-2661 (2000).
Singh et al., “Quercetin, a Bioflavonoid, Reverses Development of Tolerance and Dependence to Morphine”, Drug Development Research, 2002, vol. 57, pp. 167-172.
Pan et al. “Oxidative stree in heroin administered mice and natural antioxidants protection.” Life Sciences, Pergamon Press, Oxford, GB, vol. 77, No. 2, May 27, 2005, pp. 183-193.
Kim Jennifer M
Occhiuti Rohlicek & Tsao LLP
Quercegen Pharmaceuticals LLC
LandOfFree
Method for treating addiction using quercetin-containing... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for treating addiction using quercetin-containing..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for treating addiction using quercetin-containing... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4275891